Advanced Search

 

Study ID Status Title Patient Level Data
29060/151 Completed A study to assess the CNS effects of paroxetine (BRL 29060A) and amitriptyline and their interaction with alcohol
29060/152 Completed Two-part sequential study of the pharmacokinetic profile of 30 mg tablets of paroxetine after morning and evening administration
29060/153 Completed An investigation into the pharmacokinetics of BRL 29060 (paroxetine) in patients with impaired renal function
29060/154 Completed Two-part sequential study comparing absorption of 30 mg tablets of paroxetine in fasting and non-fasting volunteers
29060/155 Completed A study to assess the CNS effects of oxazepam alone and in combination with paroxetine
29060/156 Completed A study to assess the CNS effects of paroxetine, and haloperidol and any interaction of paroxetine with the sedative effects of haloperidol
29060/157 Completed Bioequivalence of four formulations of paroxetine
29060/158 Completed A placebo controlled, double-blind, 28 day repeat dose tolerance study on paroxetine
29060/159 Completed Double-blind tolerance study of 40 mg of paroxetine.
29060/160 Completed Bioavailability of two formulations of paroxetine
29060/161 Completed An investigation into the action of oral paroxetine on upper gastro-intestinal activity in man using the lactulose/breath hydrogen method
29060/162 Completed An investigation into the action of oral paroxetine on upper gastro-intestinal activity in man.
29060/163 Completed A study to assess the pharmacokinetics and tolerance of single oral doses and repeat oral doses of paroxetine in healthy elderly subjects and a control population.
29060/164 Completed A study to assess the pharmacokinetics and tolerance of single and repeat oral doses of paroxetine in healthy elderly subjects and a young adult control group.
29060/165 Completed Pharmacokinetics of paroxetine in patients with hepatic dysfunction
29060/166 Completed Study to elucidate any interaction between four anticonvulsants and paroxetine
29060/167 Completed An investigation into the action of oral paroxetine on upper gastro-intestinal activity in man using the lactulose/breath hydrogen method
29060/168 Completed An open two-part crossover study in healthy male volunteers to examine the effects of co-administration of Aludrox on the pharmacokinetics of BRL 29060 (paroxetine) after single oral dose of 30 mg BRL 29060
29060/169 Completed Pharmacokinetics of paroxetine before and after an eventual liver enzyme induction caused by multiple oral dosing of phenobarbitone to healthy male volunteers
29060/170 Completed A single-blind study to examine the pharmacokinetics and tolerance of paroxetine and propranolol and any interaction between them under steady state conditions
29060/171 Completed Pharmacokinetics and effects of tranylcypromine and paroxetine and any interaction between them in healthy male volunteers
29060/172 Completed A single-blind, two-part, placebo-controlled study to investigate the pharmacokinetics and effects of paroxetine (BRL 29060A) and procyclidine and any interaction between them in healthy male volunteers
29060/173 Completed An open two-part study to investigate the effects of paroxetine (BRL 29060) on the pharmacokinetics of digoxin and cardiovascular tolerance
29060/174 Completed An open study for the pharmacokinetics of orally administered paroxetine before and after oral administration of cimetidine to healthy male volunteers.
29060/175 Completed An open two-part crossover study to investigate bioavailability of BRL 29060 (Paroxetine) in healthy male volunteers after a single oral dose of 30mg BRL 29060 with a high fat and a low fat diet.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.